Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01CD04	CABAZITAXEL EVER PHARMA	G	Cabazitaxel - 60mg/6ml	10mg/ml	Injectable concentrate for solution	L.L
J01DB05	CEFADRIL	G	Cefadroxil (monohydrate) - 500mg	500mg	Capsule	450,187 L.L
D10AF01	CLINIDERM	G	Clindamycin (phosphate) - 1%	1%	Gel	712,876 L.L
B05XA01	CHLORURE DE POTASSIUM PROAMP	G	Potassium chloride - 0.0746g/ml	0.0746g/ml	Injectable concentrated solution	1,252,461 L.L
R06AX13	CLARA	G	Loratadine (micronised) - 5mg/5ml	5mg/5ml	Syrup	215,015 L.L
B05XA01	CHLORURE DE POTASSIUM RENAUDIN	G	Potassium chloride - 7.46g/100ml	7.46%	Injectable solution	385,683 L.L
J01DC02	CEFUMAX	G	Cefuroxime (sodium) - 750mg	750mg	Injectable dry powder	159,917 L.L
J01DC02	CEFUROXIME – PANPHARMAPOUDRE POUR SOLUTION INJ. IM/IV	G	Cefuroxime (sodium) - 750mg	750mg	Injectable dry powder	3,922,676 L.L
B05XA01	CHLORURE DE POTASSIUM RENAUDIN	G	Potassium chloride - 10g/100ml	10g/100ml	Injectable solution	360,150 L.L
J01DC02	CEFUROXIME – PANPHARMAPOUDRE POUR SOLUTION INJ. IM/IV	G	Cefuroxime (sodium) - 750mg	750mg	Injectable powder for solution	1,651,582 L.L
R02A	CHLORASEPTIC TOTAL SORE THROAT + COUGH LOZENGES WILD CHERRY	G	Benzocaine - 6mg, Dextromethorphan - 5mg, Menthol - 10mg		Lozenge	537,537 L.L
J01DC02	CEFUZIME	G	Cefuroxime (sodium) - 750mg	750mg	Injectable dry powder	147,823 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 5mg	5mg	Tablet	95,532,998 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 15mg	15mg	Tablet	188,515,591 L.L
A11CC05	CHOLECALCIFEROL BIOGARAN	G	Vitamin D3 - 100,000UI/2ml	100,000UI	Solution	115,570 L.L
D10BA01	CURACNE	G	Isotretinoin - 10mg	10mg	Capsule, soft gelatin	970,254 L.L
D10BA01	CURACNE	G	Isotretinoin - 10mg	10mg	Capsule, soft gelatin	970,254 L.L
J01DC02	CEFORA	G	Cefuroxime (axetil) - 500mg	500mg	Tablet	703,918 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 20mg	20mg	Tablet	188,515,591 L.L
N06AB10	CITOLES	G	Escitalopram (oxalate) - 10mg	10mg	Tablet, film coated	511,940 L.L
D10BA01	CURACNE	G	Isotretinoin - 10mg	10mg	Capsule, soft gelatin	970,254 L.L
J01DC02	CEFUREX	G	Cefuroxime - 500mg	500mg	Tablet	490,503 L.L
N06AB10	CITOXAL	G	Escitalopram (oxalate) - 10mg	10mg	Tablet, film coated	1,410,395 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 5mg	5mg	Tablet	L.L
D10BA01	CURACNE	G	Isotretinoin - 10mg	10mg	Capsule, soft gelatin	970,254 L.L
J01DC02	CEFUZIME	G	Cefuroxime (axetil) - 500mg	500mg	Tablet, film coated	490,503 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 15mg	15mg	Tablet	L.L
B03BA01	COBAL	G	Vitamin B12 - 500mcg	500mcg	Tablet, coated	486,471 L.L
L01EJ01	CELEZON	G	Ruxolitinib - 20mg	20mg	Tablet	L.L
B03BA01	CYNOVIT-JULPHAR	G	Vitamin B12 - 1mg/ml	1mg/ml	Injectable solution	167,980 L.L

...